Actively Recruiting

Phase Not Applicable
Age: 3Years - 6Years
All Genders
NCT07553247

Clinical Performance of Laryseal Clear Versus Ambu Aura 40 Laryngeal Mask Airway for Preschool Children

Led by Zagazig University · Updated on 2026-04-30

54

Participants Needed

1

Research Sites

53 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Preschool children have specific anatomical and physiological characteristics which necessitates careful selection of an appropriate airway management device. Supraglottic airway devices can be used in anticipated or unanticipated difficult airway providing continuous oxygenation and ventilation with less hemodynamic stress response and less postoperative complications. So alternative techniques such as SADs have gained prominence in pediatric anesthesia both as primary airway and as a conduit for endotracheal intubation. So this study will evaluate the clinical performance of Laryseal Clear and Ambu Aura40 laryngeal mask airway in preschool children undergoing surgical procedures.

CONDITIONS

Official Title

Clinical Performance of Laryseal Clear Versus Ambu Aura 40 Laryngeal Mask Airway for Preschool Children

Who Can Participate

Age: 3Years - 6Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Consent of patient's parents or guardians of the first degree.
  • American Society of Anesthesiologists (ASA) Class I or II.
  • BMI between 5th and 85th percentile for age and sex.
  • Mallampati airway grade I or II.
  • Scheduled for general anesthesia expected to last less than 2 hours.
Not Eligible

You will not qualify if you...

  • Emergency surgeries.
  • Expected difficult airway.
  • Presence of congenital or acquired airway malformations.
  • Active upper respiratory tract infection at time of surgery.
  • History of gastroesophageal reflux disease (GERD).
  • Neuromuscular disorders affecting airway tone or respiratory function.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Zagazig university hospitals

Zagazig, Sharqia Province, Egypt

Actively Recruiting

Loading map...

Research Team

R

Rania Kamel, MD

CONTACT

A

Amany Rabie, MBBCH

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here